The two-day conclave by NHM Blood Cell and Hemophilia Society Vijayawada brought experts and patients together to chart a roadmap for better hemophilia care.

If you bruise easily, it could be more than delicate skin. Haemophilia B is a rare bleeding disorder that often goes undiagnosed. Learn about its signs, causes, and treatment with expert insights.

The Truth Behind Some Of The Most Common Myths About Haemophilia According to a doctor, dispelling myths is crucial for fostering an accurate understanding of haemophilia and the experiences of ...

“The National Haemophilia Council and the Irish Haemophilia Society work to support people with Haemophilia and raise awareness of all bleeding disorders in Ireland.” ...

Learn about haemophilia, a genetic blood disorder, on World Haemophilia Day 2025. Know its causes, symptoms, and preventive measures. Understand how to manage and support those affected by this ...

The theme for World Haemophilia Day 2025, “Women and Girls Bleed Too,” seeks to challenge long-held assumptions that bleeding disorders affect only males.

World Haemophilia Day is celebrated every year on April 17 and various camps are held to spread awareness about the disease.

Vienna, Austria – 9 April 2025 - CSL Behring Austria today announced that the first haemophilia B patient in Austria was treated with the gene therapy HEMGENIX ® (etranacogene dezaparvovec) at the ...

Sobi® in the UK today announced that the National Institute for Health and Care Excellence (NICE) has issued its Final Guidance in England and Wales recommending the use of Altuvoct (efanesoctocog ...

Maharashtra haemophilia patients face medicine shortages, forcing travel to Gujarat for treatment, risking health and demanding urgent government action.

Karimnagar: The Haemophilia Society Peddapalli Chapter organised a Continuing Medical Education (CME) programme and distributed free Factor-8 medicine to haemophilia patients at the Government ...

NICE has recommended efanesoctocog alfa for severe haemophilia A, offering weekly dosing and improved bleeding control for patients aged 2 years and over.